Ventripoint Diagnostics Extends Convertible Debenture Offering

VentriPoint Diagnostics (TSE:VPT) has released an update.

Ventripoint Diagnostics Ltd. has announced an extension of its non-brokered private placement of convertible debentures, aiming to raise funds for operational costs and growth. The debentures offer a conversion option into common shares and bear an interest rate of 10% annually. This initiative is part of Ventripoint’s strategy to bolster its sales, marketing, and overall business operations.

For further insights into TSE:VPT stock, check out TipRanks’ Stock Analysis page.